BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Quercetin
,
rs3825942
,
PTEN
,
G-protein-coupled receptor binding
,
Ischemia
,
Stem cell
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
sialic acid receptor
(compound)
Summary
General Info
Genetic Markers
Most Correlated Genes
No genes found
Explore Genetic Markers Results
Pathway Enrichment
Most Correlated Biogroups
No biogroups found
Explore Pathway Enrichment Results
Curated Studies
Most Correlated Studies
Severe preeclampsia-related changes in gene expression
Leukocytes from fetal hearts with congenital heart block
Explore Curated Studies Results
Literature
Most Relevant Literature
Exploration of sialic acid receptors as a potential target for cancer treatment: A comprehensive rev…
Type and abundance of sialic acid receptors on host cell membrane affect infectivity and viral titer…
CMAS and ST3GAL4 Play an Important Role in the Adsorption of Influenza Virus by Affecting the Synthe…
Sequence dynamics of three influenza A virus strains grown in different MDCK cell lines, including t…
Gradual adaptation of animal influenza A viruses to human-type sialic acid receptors.
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Influenza Antiviral DAS181-F03
"Don't Eat me" Signal in Hematological Malignancies: CD24 as New Target to Improve Anti-cancer Immun…
The Effects of Neuraminidase Inhibitor Oseltamivir in Patients With Chronic Heart Failure
International Milk Composition (IMiC) Consortium
Combination of Midostaurin and Gemtuzumab Ozogamicin in First-line Standard Therapy for Acute Myeloi…
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ